DrugDashboards

Oxymorphone Hydrochloride

Oxymorphone Hydrochloride · OXYMORPHONE HYDROCHLORIDE 5 mg/1 · Tablet · Patheon Manufacturing Services LLC

NDC 63552-0090-00 · 252 BOTTLE in 1 CASE / 100 TABLET in 1 BOTTLE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 10702-0070-06) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$1.62per unit
middle half $0.8183–$1.79 · 220 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $1.62
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
4%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 87%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Oxymorphone Hydrochloride (Tablet)

LabelerStrengthFirst seenLast seen
Aurolife Pharma, LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aurolife Pharma, LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, IncOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, IncOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Oxymorphone Hydrochloride — NDC 63552-0090-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63552009000.

Free to cite with attribution — see how the data is put together.